Keyphrases
Liquid Chromatography-tandem Mass Spectrometry (LC-MS/MS)
100%
SRAGE
100%
Immunoaffinity Enrichment
20%
Early Detection
10%
Clinical Trials
10%
COPD Patients
10%
Emphysema
10%
Serum Levels
10%
Solid-phase Extraction
10%
Clinically Significant
10%
Commercially Available
10%
Validation Studies
10%
Specimen Preparation
10%
Mass Spectrometry Methods
10%
Circulating Levels
10%
Biomarker Validation
10%
Sample Preparation
10%
Mass Spectrometry Analysis
10%
Human Serum
10%
Multiple Reaction Monitoring Mode
10%
Non-smoking
10%
Acute Exacerbation of COPD (AECOPD)
10%
Strong Cation Exchange
10%
FEV1 Decline
10%
Neutrophilic Inflammation
10%
Unbound Fraction
10%
ELISA Kit
10%
Smoking Control
10%
Promising Biomarkers
10%
Antibody-free
10%
Biochemistry, Genetics and Molecular Biology
Liquid Chromatography-Mass Spectrometry
100%
Antibody Affinity
66%
Clinical Trial
33%
Biomarker Validation
33%
Blood Level
33%
Solid Phase Extraction
33%
Serum (Blood)
33%
Mass Spectrometry
33%
Cation Exchange
33%
Chemistry
Biological Marker
100%
Liquid Chromatography Mass Spectrometry (LCMS)
100%
Enzyme-Linked Immunosorbent Assay
50%
Solid-Phase Extraction
25%
Cation
25%
Mass Spectrometry
25%
Serum Level
25%
Sample Preparation Method
25%